Trial Profile
Phase III US study of orally administered monascus [XueZhiKang] in patients with hyperlipidaemia
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 21 Feb 2014
Price :
$35
*
At a glance
- Drugs Monascus (Primary)
- Indications Hyperlipidaemia
- Focus Registrational; Therapeutic Use
- 21 Feb 2014 New trial record